Retrospective Study
Copyright ©The Author(s) 2025.
World J Gastrointest Surg. May 27, 2025; 17(5): 101605
Published online May 27, 2025. doi: 10.4240/wjgs.v17.i5.101605
Table 3 Comparative analysis of immunological biomarker responses between the two groups, mean ± SD

Experimental group (n = 45)
Control group (n = 44)
F value
P value
CD3+, %43.869< 0.001
    Before treatment54.09 ± 5.3353.93 ± 5.210.0110.918
    3 months after treatment69.18 ± 7.0359.46 ± 6.72
CD4+, %39.005< 0.001
    Before treatment32.64 ± 3.8433.03 ± 3.791.2230.272
    3 months after treatment45.18 ± 4.9139.06 ± 4.23
CD8+, %84.859< 0.001
    Before treatment30.55 ± 4.5231.13 ± 4.780.1580.692
    3 months after treatment21.76 ± 2.1526.35 ± 2.52
CD4+/CD8+103.782< 0.001
    Before treatment1.10 ± 0.241.09 ± 0.220.6430.425
    3 months after treatment2.10 ± 0.331.50 ± 0.22